C-squared PHARMA Sarl:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:C-squared PHARMA Sarl - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11137
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:14
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ルクセンブルク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C-squared PHARMA Sarl (C-squared PHARMA), formerly Centroflora CMS Sarl, is a pharmaceutical company that focuses on the manufacturing and commercialization of active pharmaceutical ingredients (APl) and complex chemical compounds from phytochemical and chemical origins. The company’s product portfolio includes atropine, digoxin, homatropine, pilocarpine and hyoscine butylbromide among others. C-squared PHARMA also provides contract manufacturing services for phytochemicals and botanical extracts; and bio-based research and development services. The company commercializes its products and services in the US, Western and Eastern Europe, South America, Asia, Middle-East and Africa. It has presence in the US and Germany. C-squared PHARMA is headquartered in Luxembourg City, Luxembourg.

C-squared PHARMA Sarl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
C-squared PHARMA Acquires Phytochemical API Portfolio from Boehringer Ingelheim 10
Partnerships 11
Boehringer Ingelheim Enters into Distribution Agreement with C-squared PHARMA 11
Acquisition 12
C-squared PHARMA Acquires Remaining 50% Joint Venture Stake from PAMA Holding 12
C-squared PHARMA Sarl – Locations And Subsidiaries 13
Head Office 13
Appendix 14
Methodology 14
About GlobalData 14
Contact Us 14
Disclaimer 14

List of Tables
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Key Facts 2
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
C-squared PHARMA Sarl, Deals By Therapy Area, 2012 to YTD 2018 8
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
C-squared PHARMA Acquires Phytochemical API Portfolio from Boehringer Ingelheim 10
Boehringer Ingelheim Enters into Distribution Agreement with C-squared PHARMA 11
C-squared PHARMA Acquires Remaining 50% Joint Venture Stake from PAMA Holding 12

List of Figures
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
C-squared PHARMA Sarl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[C-squared PHARMA Sarl:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gamma Medica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gamma Medica Inc (Gamma Medica), formerly Gamma Medica Ideas Inc is a medical device company that offers imaging solutions. The company designs, develops and manufactures imaging systems for clinical and pre-clinical applications. It offers lumagem, lumagem mbi workflow, lumagem procedure ov …
  • Tesla, Inc.:企業の戦略・SWOT・財務分析
    Tesla, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Exelon Generation Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Exelon Generation Company, LLC (Exelon Generation), a subsidiary of Exelon Corporation, generates, transmits and markets electricity. It sells renewable energy and other energy-related products and services. Geographically, it has operations in the Mid-Atlantic, Midwest, New England, New Yor …
  • Cocrystal Pharma Inc (COCP):製薬・医療:M&Aディール及び事業提携情報
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Al Ahli Bank of Kuwait KSC:企業の戦略・SWOT・財務情報
    Al Ahli Bank of Kuwait KSC - Strategy, SWOT and Corporate Finance Report Summary Al Ahli Bank of Kuwait KSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SAS Institute Inc.:企業の戦略・SWOT・財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Mudman Public Company Limited (MM):企業の財務・戦略的SWOT分析
    Mudman Public Company Limited (MM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Foodwell Corporation:企業の戦略・SWOT・財務分析
    Foodwell Corporation - Strategy, SWOT and Corporate Finance Report Summary Foodwell Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bangkok Dusit Medical Services PCL (BDMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Bangkok Dusit Medical Services PCL (BDMS) is a private hospital operator that offers healthcare services. It provides medical services and patient services in various therapeutic areas through its medical centers. BDMS operates its business through a network of hospitals namely, Bangkok Hosp …
  • Delaware Municipal Electric Corporation, Inc.:企業の戦略的SWOT分析
    Delaware Municipal Electric Corporation, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Distilleries Company of Sri Lanka PLC:企業の戦略・SWOT・財務情報
    Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report Summary Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Globe Specialty Metals, Inc.:企業の戦略・SWOT・財務分析
    Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Specialty Metals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Abano Healthcare Group Ltd (ABA):企業の財務・戦略的SWOT分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd, is a healthcare service provider that offers dental, audiology, radiology and medical services. The company also operates business in community pathology and radiology sector; and healthcare markets such as ab …
  • Global Marine Systems Ltd:電力:M&Aディール及び事業提携情報
    Summary Global Marine Systems Limited (Global Marine), a subsidiary of Bridgehouse Marine Limited, is a marine technology and engineering company. It provides submarine cable installation, maintenance and engineering services. Its capabilities include project management, subsea cable installation, s …
  • DLF Limited:企業のM&A・事業提携・投資動向
    DLF Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DLF Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Pioneer Corp:企業の戦略的SWOT分析
    Pioneer Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Shinva Medical Instrument Co Ltd (600587):医療機器:M&Aディール及び事業提携情報
    Summary Shinva Medical Instrument Co., Ltd. (Shinva Medical) manufactures and markets medical instruments and environmental protection equipment for various healthcare markets. The company’s product portfolio includes sterilizers, radiotherapy equipment, digital diagnosis equipment, surgical instrum …
  • Etiqa Insurance Berhad:企業の戦略的SWOT分析
    Etiqa Insurance Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆